iShares' URTH or Schwab's SCHF: Which International ETF Is the Better Buy?

SCHF offers a much lower 0.03% expense ratio versus 0.24% for URTH, a higher 2.9% dividend yield versus 1.4%, and stronger 1-year total return of 30.2% versus 23.1% as of June 12, 2026. URTH still leads over five years, with $1,720 growth on a $1,000 investment versus $1,592 for SCHF, but it carries heavier U.S. exposure and a 31% tech weighting. The article favors SCHF for investors seeking cheaper, non-U.S. developed market diversification.

Analysis

The real signal here is not “international vs world” but factor exposure: SCHF is a cleaner bet on cyclicals, banks, and exporters, while URTH is still a disguised U.S. mega-cap growth proxy. That matters because the current rally outside the U.S. has been driven more by FX translation, discount-rate compression, and valuation mean reversion than by a durable earnings growth inflection, so the trade is more sensitive to dollar direction than headline index labels imply.

URTH’s concentration in U.S. tech leaders creates a subtle crowding risk: investors paying an active-fund fee for what is effectively a lower-beta version of the same NASDAQ complex may be vulnerable if AI leadership broadens or fades. If U.S. megacap multiple expansion stalls, URTH can underperform both U.S. broad indices and a truly ex-U.S. basket because it inherits the crowded long-duration profile without offering meaningful geographic diversification.

SCHF’s higher yield and lower beta are not just “defensive” features; they make it more appealing in a world where real yields remain elevated and income is valued. The main upside catalyst for SCHF is continued dollar weakness over the next 3-6 months, which mechanically boosts foreign equity returns for U.S. investors and tends to favor financials and industrials over long-duration tech. The main risk is a sharp USD rebound on sticky U.S. growth or a renewed risk-off shock, which would hit SCHF faster than URTH because it lacks the embedded U.S. earnings hedge.

Consensus may be underestimating how much of URTH’s recent performance can be explained by a narrow set of U.S. winners rather than global diversification. In other words, URTH is less a world fund than a high-cost wrapper around the same names many portfolios already own, while SCHF is the more differentiated source of international beta. The asymmetry is that SCHF can continue to outperform if the dollar weakens modestly and non-U.S. multiples re-rate, but URTH needs the U.S. tech complex to keep doing the heavy lifting just to stay competitive.

Key Decisions for Investors

• Rotate fresh international allocation into SCHF over URTH over the next 2-4 weeks; use URTH only if the mandate specifically requires U.S. overlap. Risk/reward favors SCHF because the fee gap compounds and the basket is less redundant with existing domestic exposure.
• Pair trade: long SCHF / short QQQ or IWF for 3-6 months if the dollar remains soft and rates stay range-bound. Thesis is factor diversification: ex-U.S. financials and industrials should catch up while long-duration U.S. megacaps consolidate.
• If you need global developed exposure but already own U.S. large cap, avoid adding URTH at current levels; instead consider a staged SCHF buy on any 2-3% pullback. The cleaner diversification hedge is worth more than the incremental U.S. tech duplication.
• For tactical traders, sell upside calls on URTH against a small long if you want to harvest premium from crowded mega-cap ownership. The fund’s embedded concentration makes it more prone to mean reversion if one or two leaders wobble.
• Watch DXY and U.S. 10-year real yields as trigger variables: if the dollar breaks higher or real yields re-accelerate, trim SCHF exposure first; if both stay soft, add to SCHF and underweight URTH.